LNTH

#1285
Lantheus Holdings, Inc
82.7400 USD
+1.31%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
82.7400
82.7400
Jahresspanne
50.1550
84.3800
Tagesänderung
+1.31%
Monatliche Änderung
+3.42%
6 month change
+47.59%
Jahresänderung
+47.59%
Vorheriger Schlusskurs
81.6700
Eröffnung
82.7400
Bid
Ask
Tief
82.7400
High
82.7400
Volumen
63
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 5.3455 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
19.52
Preis-Umsatz-Verhältnis
2.95

Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Nachrichten